Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-13

Clinical Trial Update: Haloperidol vs Conventional Therapy for Gastroparesis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing haloperidol to conventional therapy for gastroparesis was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Gastroparesis | Phase 4 | Status: TERMINATED | Results posted: 2017-07-13